NEW YORK (GenomeWeb) – Three co-founders of 10X Genomics have prevailed in an arbitration dispute brought against them by Bio-Rad Laboratories, 10X Genomics said today.

According to 10X, Bio-Rad brought a claim before the American Arbitration Association in September of 2014, alleging that the three company founders — Serge Saxonov, Benjamin Hindson, and Kevin Ness — had breached certain contractual non-compete, non-solicitation, and confidentiality obligations they allegedly owed to Bio-Rad after it acquired Quantalife in 2011, where all three worked at the time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.